Evidence map›Paper›PMID 35072735›Full record

ReviewApplied microbiology and biotechnology2022

Nicotine metabolism pathway in bacteria: mechanism, modification, and application.

Zeling Zhang, Xiaotong Mei, Ziliang He, Xiya Xie, Yang Yang, Chengyu Mei, Dong Xue, Tong Hu, Ming Shu, Weihong Zhong

Abstract readReview
PubMed Publisher
In one paragraph

Review in Applied microbiology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Hyperin application modulates leaf bacterial communities and reduces tobacco-specific nitrosamines in air-cured Burley tobacco.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
  3. Article
  4. Article
  5. Microbial community assembly in the fermentation of cigar tobacco leaves.Frontiers in bioengineering and biotechnology · 2026
    Review
  6. Article
  7. Article
  8. Macrotranscriptomics analysis for decoding the role ofFrontiers in bioengineering and biotechnology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Rational Design of a Flavoenzyme for Aerobic Nicotine Catabolism.bioRxiv : the preprint server for biology · 2024
    Article
  13. Article
  14. Unravel the Supremacy ofMetabolites · 2024
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Zeling ZhangCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Xiaotong MeiCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Ziliang HeCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Xiya XieCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Yang YangTechnology Center, China Tobacco Zhejiang Industrial Co., Ltd, Hangzhou, 310009, People's Republic of China. Yangy@zjtobacco.com.
Chengyu MeiCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Dong XueCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Tong HuCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China.
Ming ShuTechnology Center, China Tobacco Zhejiang Industrial Co., Ltd, Hangzhou, 310009, People's Republic of China.
Weihong ZhongCollege of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, People's Republic of China. whzhong@zjut.edu.cn.ORCID http://orcid.org/0000-0002-5673-2222
Zhejiang University of Technology · CNChina Tobacco · CN

Funding

National Natural Science Foundation of China 21938012National Natural Science Foundation of China 31670115National Natural Science Foundation of China No. 31970104
6 · The paper itself

Abstract

Nicotine is a harmful pollutant mainly from the waste of tobacco factories. It is necessary to remove nicotine via high efficient strategies such as bioremediation. So far, an increasing number of nicotine degrading strains have been isolated. However, their degrading efficiency and tolerance to high content nicotine is still not high enough for application in real environment. Thus, the modification of nicotine metabolism pathway is obligated and requires comprehensive molecular insights into whole cell metabolism of nicotine degrading strains. Obviously, the development of multi-omics technology has accelerated the mechanism study on microbial degradation of nicotine and supplied more novel strategy of strains modification. So far, three pathways of nicotine degradation, pyridine pathway, pyrrolidine pathway, and the variant of pyridine and pyrrolidine pathway (VPP pathway), have been clearly identified in bacteria. Muti-omics analysis further revealed specific genome architecture, regulation mechanism, and specific genes or enzymes of three pathways, in different strains. Especially, muti-omics analysis revealed that functional modules coexisted in different genome loci and played additional roles on enhanced degradation efficiency in bacteria. Based on the above discovery, genomic editing strategy becomes more feasible to greatly improve bacterial degrading efficiency of nicotine.

Indexed as

Metabolic Networks and PathwaysNicotineBacteriaBiodegradation, EnvironmentalTobacco ProductsNicotineGenome editingMetabolic pathwayNicotine biodegradation

Identifiers

PMID35072735
OpenAlexW4206924277

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.